AIP4 is the first comprehensively integrated platform from disease diagnosis to drug development based on our twenty years＇ accumulation of computational biology, drug development, clinical, pharmaceuticalindustrial breakthrough progress, achievementsknowledge bases, such as patents, the cross-species drug-protein-network-disease big data databasethe membrane protein-mutation-disease database.

AIP4 accumulated about a hundred publications. We found that hundreds of molecular Interaction Building Blocks are the basic elements to form biological phenomena, equivalent to four types of nucleobase in DNAtwenty types of amino acids in protein. Based on this scientific concept, we overcome technical hurdles to investigate biological dynamic network models. We integrate from disease sub-ty

AIP4 links basic research, translational medicineindustry based on our core value. We obtained 3 USTaiwan patents, which had been successfully applied to six major servicescan be customized for different cases, so there is a wide potential customer group. We had closely collaborated to industry, hospitalacademic groups, so we can immediately provide products according to custom